exhibit guide - androgen society

Androgen Society

A N D R O G E N S O C I E T Y

3rd Annual Meeting

March 12 – 14, 2021Virtual Meeting

President Abraham Morgentaler, MD welcomes you to the Androgen Society 3rd Annual Meeting.

EXHIBIT GUIDE

of the Androgen Society 3rd Annual Meeting

PROUDPLATINUM SPONSOR

Actor portrayal.

Learn more at NATESTOHCP.COM/AS2021

©2021 Acerus Pharmaceuticals Corporation

Natesto is a registered trademark of Acerus Biopharma Inc. Any and all use of the word Natesto, with or without the registered trademark symbol, is used in connection with such trademark rights.

The ACERUS PHARMA logo is a trademark of Acerus Pharmaceuticals Corporation.

NAT-US-0050 02/21

https://www.natestohcp.com/?utm_source=Androgen_Society_Ad&utm_medium=redirect&utm_campaign=Digital_Ad_AS_3rd_Annual_Meeting&utm_content=NATESTOHCP_COM_AS2021

https://www.mariuspharma.com/

HEADER

4 The Androgen Society 3rd Annual Meeting

SCIENTIFIC PROGRAMFRIDAY, MARCH 12, 2021

8:00 a.m. - 8:05 a.m. Welcome Remarks President: Abraham Morgentaler, MD

8:05 a.m. - 8:10 a.m. Androgen Society Journal Announcement Speaker: Abdulmaged M. Traish, MBA, PhD

8:10 a.m. - 8:50 a.m. The History of Testosterone Speaker: Eberhard Nieschlag, MD

8:50 a.m. - 9:10 a.m. Challenges of Creating an Academic Trans-Gender Surgery Program Speaker: Ethan D. Grober, MD

9:10 a.m. - 9:30 a.m. How To Manage Testosterone Therapy in Transmen Speaker: Michael S. Irwig, MD,FACE

9:30 a.m. - 10:15 a.m. Clinical Case Discussion Moderator: Abraham Morgentaler, MD Panelists: Sandeep Dhindsa, MD Mohit Khera, MD, MBA, MPH Peter H. Lim, MD Ernani Luis Rhoden, MD,PhD

10:15 a.m. - 11:15 a.m. Abstract Session Moderators: Hugh Jones, MD Abdulmaged M. Traish, MBA, PhD

11:15 a.m. - 11:25 a.m. CME Break

11:25 a.m. - 12:15 p.m. Androgen Deprivation Therapy - Beneficial and Adverse Effects Moderator: Hugh Jones, MD

11:25 a.m. - 11:35 a.m. Androgen Deprivation Therapy: The Foundation of advanced prostate cancer treatment Speaker: E. David Crawford, MD

11:35 a.m. - 11:55 a.m. ADT and Sexual Function Speaker: Omer Raheem, MD

11:55 a.m. - 12:15 p.m. CV/Metabolic Adverse Effects of ADT Speaker: E. David Crawford, MD

12:15 p.m. - 12:45 p.m. New Formulations for Andrology Moderators: Peter H. Lim, MD Martin Miner, MD

12:15 p.m. - 12:30 p.m. New Oral Testosterone Preparations Speaker: Mohit Khera, MD, MBA, MPH

12:30 p.m. - 12:45 p.m. New Injectable Preparations of Testosterone Speaker: Adrian S. Dobs, MD, MHS

12:45 p.m. - 12:55 p.m. Grandmaster of Testosterone Award Presentation Presenter: Abraham Morgentaler, MD Recipient: Eberhard Nieschlag, MD

12:55 p.m. - 1:05 p.m. Questions and Discussion

All sessions are listed in Eastern Time and will be conducted via Zoom Webinar.

HEADER


SCIENTIFIC PROGRAMSATURDAY, MARCH 13, 2021

8:00 a.m. - 9:30 a.m. Testosterone-Prevention, Control and Remission of Type 2 Diabetes Mellitus Moderator: Paresh Dandona, MD

8:00 a.m. - 8:25 a.m. The T4D Study Speaker: Gary Wittert

8:25 a.m. - 8:45 a.m. Does Testosterone Improve Glycaemic Control in T2D Speaker: Hugh Jones, MD

8:45 a.m. - 9:05 a.m. Evidence that Testosterone Therapy Could Lead to Remission of T2D Speaker: Farid Saad, DVM, PhD 9:05 a.m. - 9:25 a.m. Testosterone Therapy: Anaemia and Hematocrit Speaker: Sudarshan Ramachandran, PhD

9:25 a.m. - 9:30 a.m. Questions and Discussion

9:30 a.m. - 10:05 a.m. New Concepts and Challenges in the Field of Androgens Moderators: Peter H. Lim, MD Abraham Morgentaler, MD

9:30 a.m. - 9:45 a.m. Testosterone Therapy and Prostate Cancer Speaker: Mohit Khera, MD, MBA, MPH

9:45 a.m. - 10:05 a.m. Panel Discussion: Testosterone and Prostate Cancer Panelists: E. David Crawford, MD Mohit Khera, MD, MBA, MPH Ernani Luis Rhoden, MD,PhD

10:05 a.m. - 10:25 a.m. COVID and Testosterone Speaker: Mary K. Samplaski, MD

10:25 a.m. - 11:15 a.m. Testosterone in Women Moderators: Mohit Khera, MD, MBA, MPH Abdulmaged M. Traish, MBA, PhD

10:25 a.m. - 10:45 a.m. Testosterone Therapy for Women - New Guidelines Speaker: Sharon Parish, MD, IF

10:45 a.m. - 11:05 a.m. Androgens and Libido in Women Speaker: Leah Millheiser, MD, FACOG, NCMP

11:05 a.m. - 11:15 a.m. Questions and Discussion

11:15 a.m. - 11:25 a.m. CME Break

11:25 a.m. - 12:15 p.m. Testosterone, Inflammation and Atherosclerosis Moderators: Hugh Jones, MD Martin Miner, MD

11:25 a.m. - 11:45 a.m. Science of Testosterone and Atherosclerosis Speaker: Daniel Kelly, PhD

11:45 a.m. - 12:05 p.m. Effects of Androgens on Inflammation Speaker: Abdulmaged M. Traish, MBA, PhD

12:05 p.m. - 12:15 p.m. Questions and Discussion

12:15 p.m. - 1:15 p.m. Abstract Session


HEADER


SCIENTIFIC PROGRAMSUNDAY, MARCH 14, 2021

8:00 a.m. - 8:35 a.m. Debate: The Correct Threshold for Diagnosis of Testosterone Deficiency is 300 ng/dl (10.4 nmol/L) Debaters: Jean Paul Deslypere, MD, PhD Martin Miner, MD

8:35 a.m. - 9:00 a.m. The Role of Active Metabolites of Testosterone in Men Speaker: Jean Paul Deslypere, MD, PhD

9:00 a.m. - 9:20 a.m. Clinical Implications of Differences in Androgen Receptor Sensitivity Speaker: Hugh Jones, MD

9:20 a.m. - 9:50 a.m. Keynote: Testosterone, Science and Human Dignity Speaker: Abraham Morgentaler, MD

9:50 a.m. - 10:05 a.m. Dedication to Education Award Presentation Presenter: Abraham Morgentaler, MD Recipient: Abdulmaged M. Traish, MBA, PhD

10:05 a.m. - 10:45 a.m. Controversies in Treatment of Testosterone Deficiency

10:05 a.m. - 10:25 a.m. Recovery of Spermatogenesis following Testosterone Therapy or Anabolic Steroid Use Speaker: Larry I. Lipshultz, MD

10:25 a.m. - 10:45 a.m. Should Age Related Testosterone Deficiency be Treated Speaker: Abdulmaged M. Traish, MBA, PhD

10:45 a.m. - 10:55 a.m. CME Break

10:55 a.m. - 11:15 a.m. Mood, Depression and Dementia Speaker: Martin Miner, MD

11:15 a.m. - 11:35 a.m. Menage A Trois: Sex, Androgens and Dry Eye Disease Speaker: David Sullivan, PhD

11:35 a.m. - 11:50 a.m. Treatment of Hypogonadism Induced Gynecomastia Speaker: Ernani Luis Rhoden, MD,PhD

11:50 a.m. - 12:30 p.m. Debate: Testosterone Therapy Should Be Used as a Monotherapy for ED in Men with Testosterone Deficiency Moderator: Omer Raheem, MD Debater: Michael Kirby, FRCP Allen D. Seftel, MD, FACS

12:30 p.m. - 12:45 p.m. Closing Remarks President: Abraham Morgentaler, MD


HEADER


INDUSTRY SUPPORTPLATINUM LEVEL

GOLD LEVEL

SILVER LEVEL

Endo Pharmaceuticals is putting a

spotlight on men’s health. We’ve

launched Endo Men’s Health to start

a critical conversation. Men need a

“GUY-NECOLOGIST.” No healthcare

professional is as expert on sexual

men’s health issues as a urologist.

M E N M AY N O T B E TA LK ING A BOU T T H E IR H E A LT H.

BUT WE ARE.

© 2019 Endo Pharmaceuticals Inc. All rights reserved. Malvern, PA 19355MH-05048/April 2019 www.endo.com 1-800-462-ENDO (3636)

VISIT

ENDOMENSHEALTH.COMTO LEARN MORE

https://www.endo.com/endopharma/therapeutic-areas/urology-mens-health

Androgen Society

Androgen SocietyTwo Woodfield Lake

1100 E. Woodfield Road, Suite 350Schaumburg, IL 60173

Learn more

https://www.jatenzo.com/hcp/?utm_medium=display&utm_source=meeting+guide&utm_id=DS210211193001

exhibit guide - androgen society

Documents